Per Hellsund is the founder of Cybrexa Therapeutics. Cybrexa Therapeutics has raised $6M in total funding. Latest round: Series B.
Per Hellsund is the CEO of Cybrexa Therapeutics, an oncology biotechnology company based in New Haven, developing peptide drug conjugate therapies. He is described as a bioscience entrepreneur and has been with Cybrexa Therapeutics since January 2017.
Full founder directory · Investor directory · Company funding database · Fundraising library